en
Scientific article
Letter
English

Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm

Published inLeukemia and Lymphoma, vol. 61, no. 9, p. 2226-2229
Publication date2020
Keywords
  • Humans Hypereosinophilic Syndrome* Imatinib Mesylate / therapeutic use Leukoencephalopathy
  • Progressive Multifocal* / diagnosis Leukoencephalopathy
  • Progressive Multifocal* / drug therapy Myeloproliferative Disorders* / complications Myeloproliferative Disorders* / diagnosis Myeloproliferative Disorders* / drug therapy Neoplasms* Oncogene Proteins
  • Fusion / genetics Oncogene Proteins
  • Fusion / metabolism Receptor
  • Platelet-Derived Growth Factor alpha / genetics Receptor
  • Platelet-Derived Growth Factor alpha / metabolism mRNA Cleavage and Polyadenylation Factors / genetics
Citation (ISO format)
BLUM, Sabine et al. Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm. In: Leukemia and Lymphoma, 2020, vol. 61, n° 9, p. 2226–2229. doi: 10.1080/10428194.2020.1759052
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1026-8022
125views
0downloads

Technical informations

Creation10/28/2020 11:13:00 AM
First validation10/28/2020 11:13:00 AM
Update time03/16/2023 1:19:34 AM
Status update03/16/2023 1:19:32 AM
Last indexation01/17/2024 2:16:02 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack